StockData
Establishment Labs Holdings Inc. logo

Establishment Labs Holdings Inc. (ESTA) stock

ESTANasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$69.51−0.31 (-0.44%)

Close on Nov 17, 2026Market cap $2.07BP/E –Yield –

Establishment Labs r&d expenses

Research and development expenses are spending on new products and technology.

Establishment Labs's R&D Expenses for the twelve months ending Sep 30, 2026 was $20.08M, up 0.6% year over year. For fiscal 2025 it was $20.25M, up 2.7% from the year before. The highest annual figure on record is $26.43M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$20.25M+2.7%
FY2024Dec 31, 2024$19.71M-25.4%
FY2023Dec 31, 2023$26.43M+30.4%
FY2022Dec 31, 2022$20.27M+10.7%
FY2021Dec 31, 2021$18.32M+32.8%
FY2020Dec 31, 2020$13.79M-8.0%
FY2019Dec 31, 2019$14.99M+18.2%
FY2018Dec 31, 2018$12.69M+84.8%
FY2017Dec 31, 2017$6.86M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$4.31M-5.3%
Q2 FY2026Jun 30, 2026$5.10M-2.1%
Q1 FY2026Mar 31, 2026$5.24M+3.7%
Q4 FY2025Dec 31, 2025$5.43M+5.6%
Q3 FY2025Sep 30, 2025$4.56M-5.1%
Q2 FY2025Jun 30, 2025$5.20M-5.2%
Q1 FY2025Mar 31, 2025$5.06M+18.3%
Q4 FY2024Dec 31, 2024$5.14M-11.6%
Q3 FY2024Sep 30, 2024$4.80M-32.6%
Q2 FY2024Jun 30, 2024$5.49M-21.0%
Q1 FY2024Mar 31, 2024$4.27M-34.6%
Q4 FY2023Dec 31, 2023$5.82M-10.2%
Q3 FY2023Sep 30, 2023$7.13M+34.8%
Q2 FY2023Jun 30, 2023$6.95M+41.7%
Q1 FY2023Mar 31, 2023$6.53M+81.6%
Q4 FY2022Dec 31, 2022$6.48M+7.4%
Q3 FY2022Sep 30, 2022$5.29M+36.2%
Q2 FY2022Jun 30, 2022$4.90M+12.7%
Q1 FY2022Mar 31, 2022$3.60M-11.1%
Q4 FY2021Dec 31, 2021$6.03M+35.1%
Q3 FY2021Sep 30, 2021$3.88M+42.3%
Q2 FY2021Jun 30, 2021$4.35M+81.3%
Q1 FY2021Mar 31, 2021$4.05M-3.6%
Q4 FY2020Dec 31, 2020$4.47M+23.0%
Q3 FY2020Sep 30, 2020$2.73M-27.7%
Q2 FY2020Jun 30, 2020$2.40M-40.0%
Q1 FY2020Mar 31, 2020$4.20M+17.2%
Q4 FY2019Dec 31, 2019$3.63M-0.8%
Q3 FY2019Sep 30, 2019$3.78M+19.0%
Q2 FY2019Jun 30, 2019$4.00M+8.0%
Q1 FY2019Mar 31, 2019$3.58M+66.9%
Q4 FY2018Dec 31, 2018$3.66M+49.8%
Q3 FY2018Sep 30, 2018$3.17M+121.0%
Q2 FY2018Jun 30, 2018$3.71M+150.2%
Q1 FY2018Mar 31, 2018$2.15M–
Q4 FY2017Dec 31, 2017$2.44M–
Q3 FY2017Sep 30, 2017$1.44M–
Q2 FY2017Jun 30, 2017$1.48M–

More Establishment Labs figures

See a number that looks wrong?